TiumBio Rises 11.07% Amid Immune Checkpoint Inhibitor Theme Uptrend

On the 10th, the immuno-oncology theme rose 3.09% compared to the previous day, showing strength, while Tium Bio, which is attracting attention as a related stock, surged 11.07% compared to the previous day.

[Graph] Price Fluctuations of Major Immuno-Oncology Theme Stocks



According to provisional data compiled at 10:26, Tium Bio’s supply and demand are mixed between foreigners and institutions. Foreigners are selling 33,000 shares, while institutions are buying 11,000 shares.

[Table] Net Trading Volume of Foreigners and Institutions (Unit: 10,000 shares)


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.